Key Insights

Highlights

Treatment Research

2 treatments under study, led by Echocardiography

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05747404RecruitingPrimary

The FUnctional TricUspid REgurgitation by 3D EChocardiography Cooperative Study

NCT05749107UnknownPrimary

In-depth Characterization of Atriogenic Secondary Tricuspid Regurgitation Due to Atrial Fibrillation

Showing all 2 trials

Research Network

Common Treatments

  • Echocardiography2
  • Proteomic Analyses1

Active Sponsors

  • Istituto Auxologico Italiano2
  • Ministry of Health, Italy1

Top Investigators

Related Conditions

  • Atrial Fibrillation Persistent1
  • Echocardiography Transthoracic1

Activity Timeline